Lenalidomide at the dose of 25 mg every other day in patients affected by multiple myeloma and renal failure: a real-life experience. [electronic resource]
Producer: 20190408Description: 371-372 p. digitalISSN:- 1473-5741
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.